Syrris Established as Market Leader in Flow Chemistry
News Dec 12, 2012
Syrris Ltd has been identified as the leading global provider of flow chemistry equipment in a recent independent report conducted by market research experts Yole Développement.
The Company first established itself as a leader in the rapidly growing flow chemistry microreactor market with the versatile Africa flow chemistry system, and has now secured the largest market share thanks to the introduction of the pioneering Asia flow chemistry microreactor system in 2011.
The Asia series includes a range of innovative modules that can be independently configured to cover a broad variety of applications.
Its user-friendly proprietary technology allows manual or automated experiments, and the modular design makes it suitable for everything from a manually operated starter system to a fully automated reaction optimization setup with integrated analysis.
The Yole report also identifies that continued growth in this market is expected.
Syrris will be well placed to meet this expansion, thanks to a strong development pipeline and continued investment in research into new technologies, with several innovative products currently nearing commercial readiness.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018